Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2012
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2012.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
The filing text does not disclose specific material changes versus prior periods. It solely serves to notify the SEC of the issuance of a press release containing the results of operations and financial condition.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It includes a standard disclaimer stating that the information in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the three and nine months ended September 30, 2012.
- Verify year-over-year comparisons and specific drivers of performance in the referenced press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial statements.